The CureSight’s Referral Program allows eye care providers (ECP’s) to refer their amblyopic patients to CureSight, our FDA-cleared and CE marked eye-tracking-based digital treatment program for amblyopia.
Joining the program doesn’t require any investment from the clinic and can provide a new source of revenue stream.
Upon the ECP’s enrollment to the CureSight program, access is granted to a dedicated web portal. The web portal which is the beating heart of CureSight’s entirety, allows the ECP to place online referrals of the CureSight treatment as well as monitor the patient’s treatment progress and compliance.
In order to ease the load for the ECP and support the referral process, a dedicated HIPAA and GDPR compliant Monitoring Center is in place to process patient referrals while providing comprehensive end-to-end physician and patient engagement, education, and support.
The CureSight’s Referral Program allows eye care providers (ECP’s) to refer their amblyopic patients to CureSight, our FDA-cleared eye-tracking-based digital treatment program for amblyopia.
Joining the program doesn’t require any investment from the clinic and can provide a new source of revenue stream.
Upon the ECP’s enrollment to the CureSight program, access is granted to a dedicated web portal. The web portal which is the beating heart of CureSight’s entirety, allows the ECP to place online referrals of the CureSight treatment as well as monitor the patient’s treatment progress and compliance.
In order to ease the load for the ECP and support the referral process, a dedicated HIPAA-compliant Monitoring Center is in place to process patient referrals while providing comprehensive end-to-end physician and patient engagement, education, and support.
The CureSight treatment may be medically covered* through three unique Category III CPT codes – Remote treatment of amblyopia using an eye tracking device:
Device supply with initial set-up and patient education on use of equipment
Surveillance center technical support including data transmission with analysis, with a minimum of 18 training hours, each 30 days
Interpretation and report by physician or other qualified health care professional, per calendar month
The Monitoring Center bills for the initial setup (0704T) and monthly monitoring and support of the treatment (0705T) and the clinic bills for the remote medical monitoring every 30 days (0706T).
The claims adjudication process, including appeals, can be time-consuming and may even extend beyond the duration of the treatment. To address this issue, we offer our Assurance Program to patients who have entered into a Patient Agreement by December 31th, 2025. This program is designed to give your patients full control over their out-of-pocket expenses related to the use of the CureSight device, allowing them to plan their expenses effectively while being treated through the CureSight Program.
CPT = Current Procedural Terminology; HCPCS = Healthcare Common Procedure Coding System; ICD-10-CM = International Classification of Diseases, Tenth Revision, Clinical Modification.
The information provided in this Coding and Billing Information document is of a general nature and for informational purposes only and is not intended to be a comprehensive list nor instructive. Coding and coverage policies change periodically and often without warning. The responsibility to determine coverage and reimbursement parameters, and appropriate coding for a particular patient and/or procedure, is always the responsibility of the provider or physician.
The information provided in this section should in no way be considered a guarantee of coverage or reimbursement for any product or service. Providers should select the coding options that most accurately reflect their internal system guidelines, payer requirements, practice patterns, and the services rendered. Providers are responsible for ensuring the accuracy and validity of all billing and claims for appropriate reimbursement.
Copyright Notice CPT: CPT codes, descriptions and other data only are copyright (2021) American Medical Association.
All Rights Reserved.
The CureSight web portal allows the eye care provider to control and monitor their CureSight patient’s treatment. Supported by an integrated cloud platform which processes data from the CureSight system, the eye care provider has access to comprehensive treatment information such as progress reports, real-time monitoring, and compliance of the child’s treatment.
Referrals are also available through the EHR system and a fax referral
The CureSight treatment received 3 unique CPT (Current Procedural Terminology) codes from the American Medical Association becoming effective in January 2022. NovaSight is currently developing coverage plans with top payors in the US.
CureSight’s unique CPT codes (0704T-0706T) have been included in the coverage policies of two leading U.S. health insurers: Anthem-Blue Cross Blue Shield (BCBS) and Aetna.
Anthem-BCBS has updated its policy (CG-MED-102) to recognize home-based digital therapy as medically necessary for pediatric amblyopia, including CureSight’s dedicated CPT codes. In addition, Aetna has updated its Orthoptic and Vision Therapy policy (CPB 0489) to recognize CureSight as medically necessary – currently the only FDA-cleared digital therapy specifically named in the policy.
The referring physician may bill the patient’s payor for code 0706T – interpretation and report by physician or other qualified health care professional, per calendar month.
The CureSight system is indicated for improvement in visual acuity and stereo acuity in amblyopia patients, aged 4 – <9 years, associated with anisometropia and/or with mild strabismus, having received treatment instructions (frequency and duration) as prescribed by a trained eye-care professional. CureSight is intended for both previously treated and untreated patients and is intended to be used as an adjunct to full-time refractive correction, such as glasses, which should also be worn under the anaglyph glasses during CureSight treatment. CureSight is intended for prescription use only, in an at-home environment.
Once a child is diagnosed with amblyopia and prescribed with the CureSight treatment, the eye care provider creates a ‘new patient’ via the dedicated web portal. The new patient account is also going to be used as the patient’s prescription.
After receiving the prescription, the Monitoring Center makes a benefit and eligibility verification and once approved – the device is shipped to the patient’s home via FedEx.
Upon arrival – the Monitoring Center guides the patient’s guardians how to set up and operate the device and will also track the patient’s compliance to the treatment.
The treatment is carried out according to the recommended eye care provider’s protocol and the device’s instructions of use. Supported by an integrated web portal which processes data from the CureSight system, the eye care provider receives a comprehensive patient progress reports and real-time monitoring of the child’s treatment’s compliance throughout the entire treatment time.
This website uses cookies for functional, operational, analytical and advertising purposes. Please review our Privacy Policy for more information